127 related articles for article (PubMed ID: 17298920)
1. Plasmodium falciparum pyruvate kinase as a novel target for antimalarial drug-screening.
Chan M; Tan DS; Sim TS
Travel Med Infect Dis; 2007 Mar; 5(2):125-31. PubMed ID: 17298920
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from Plasmodium falciparum.
Chan M; Sim TS
Biochem Biophys Res Commun; 2005 Jan; 326(1):188-96. PubMed ID: 15567170
[TBL] [Abstract][Full Text] [Related]
3. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
Tuteja R
FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs.
Werner C; Stubbs MT; Krauth-Siegel RL; Klebe G
J Mol Biol; 2005 Jun; 349(3):597-607. PubMed ID: 15878595
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
7. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
[TBL] [Abstract][Full Text] [Related]
8. Structural model of the Plasmodium falciparum thioredoxin reductase:a novel target for antimalarial drugs.
Banerjee AK; Arora N; Murty US
J Vector Borne Dis; 2009 Sep; 46(3):171-83. PubMed ID: 19724080
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase deficiency and malaria.
Ayi K; Min-Oo G; Serghides L; Crockett M; Kirby-Allen M; Quirt I; Gros P; Kain KC
N Engl J Med; 2008 Apr; 358(17):1805-10. PubMed ID: 18420493
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium kinases as targets for new-generation antimalarials.
Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium and host lactate dehydrogenase molecular function and biological pathways: implication for antimalarial drug discovery.
Wiwanitkit V
Chem Biol Drug Des; 2007 Apr; 69(4):280-3. PubMed ID: 17461976
[TBL] [Abstract][Full Text] [Related]
12. Exploring putative molecular mechanisms of human pyruvate kinase enzyme deficiency and its role in resistance against Plasmodium falciparum malaria.
Qidwai T; Jamal F; Singh S
Interdiscip Sci; 2014 Jun; 6(2):158-66. PubMed ID: 25172454
[TBL] [Abstract][Full Text] [Related]
13. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of the gene encoding cytidine triphosphate synthetase from Plasmodium falciparum which contains two novel sequences that are potential antimalarial targets.
Yuan P; Hendriks EF; Fernandez HR; O'Sullivan WJ; Stewart TS
Mol Biochem Parasitol; 2005 Oct; 143(2):200-8. PubMed ID: 16051382
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of S-adenosyl-L-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum.
Tanaka N; Nakanishi M; Kusakabe Y; Shiraiwa K; Yabe S; Ito Y; Kitade Y; Nakamura KT
J Mol Biol; 2004 Oct; 343(4):1007-17. PubMed ID: 15476817
[TBL] [Abstract][Full Text] [Related]
16. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA
Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073
[TBL] [Abstract][Full Text] [Related]
18. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China.
Zhang GQ; Guan YY; Zheng B; Wu S; Tang LH
Trop Med Int Health; 2009 Oct; 14(10):1266-71. PubMed ID: 19772548
[TBL] [Abstract][Full Text] [Related]
19. Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro.
Ayi K; Liles WC; Gros P; Kain KC
J Infect Dis; 2009 Oct; 200(8):1289-99. PubMed ID: 19743919
[TBL] [Abstract][Full Text] [Related]
20. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.
Musset L; Le Bras J; Clain J
Mol Biol Evol; 2007 Aug; 24(8):1582-5. PubMed ID: 17488741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
